Besides induction of endothelial cell apoptosis and inhibition of new vessel formation, it is also hypothesized that anti-VEGF agents may “normalize” the tumor vessels by decreasing permeability and interstitial pressure and thus reducing hypoxia and improving delivery of cytotoxics, when given in combination [15, 16]. This evidence concerns the gene VEGFA and neoplasm.